IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TINCANI, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.142
EU - Europa 16.587
AS - Asia 7.115
AF - Africa 81
SA - Sud America 56
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 41
Totale 52.069
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.042
IT - Italia 4.187
UA - Ucraina 3.939
CN - Cina 3.613
DE - Germania 3.011
PL - Polonia 1.750
SG - Singapore 1.304
HK - Hong Kong 1.171
FI - Finlandia 895
GB - Regno Unito 685
IE - Irlanda 685
TR - Turchia 621
FR - Francia 571
RU - Federazione Russa 377
SE - Svezia 181
IN - India 168
CA - Canada 71
VN - Vietnam 62
NL - Olanda 54
AU - Australia 46
ES - Italia 45
EU - Europa 41
BE - Belgio 34
RO - Romania 28
ID - Indonesia 24
CZ - Repubblica Ceca 23
EE - Estonia 23
JP - Giappone 22
MA - Marocco 22
BR - Brasile 20
CH - Svizzera 19
EG - Egitto 18
IL - Israele 18
KR - Corea 17
AR - Argentina 16
GR - Grecia 16
IR - Iran 15
LB - Libano 14
MX - Messico 14
MU - Mauritius 12
TN - Tunisia 11
TH - Thailandia 10
DK - Danimarca 9
DZ - Algeria 7
MK - Macedonia 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
UY - Uruguay 6
AT - Austria 5
BG - Bulgaria 5
BS - Bahamas 5
HU - Ungheria 5
IQ - Iraq 5
PH - Filippine 5
PT - Portogallo 5
SA - Arabia Saudita 5
AM - Armenia 4
GE - Georgia 4
LU - Lussemburgo 4
MY - Malesia 4
RS - Serbia 4
AL - Albania 3
CY - Cipro 3
KZ - Kazakistan 3
LI - Liechtenstein 3
SI - Slovenia 3
TW - Taiwan 3
CL - Cile 2
CR - Costa Rica 2
EC - Ecuador 2
JM - Giamaica 2
JO - Giordania 2
LY - Libia 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
SN - Senegal 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MS - Montserrat 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 52.065
Salva come PNG Salva come JPEG
Città #
Fairfield 4.290
Woodbridge 3.995
Jacksonville 2.811
Houston 2.706
Ashburn 1.877
Ann Arbor 1.750
Warsaw 1.740
Cambridge 1.644
Seattle 1.621
Wilmington 1.511
Princeton 1.215
Hong Kong 1.159
Singapore 1.030
Nanjing 928
Chandler 752
Dublin 621
Istanbul 551
Beijing 522
New York 463
Helsinki 433
Milan 357
Nanchang 354
Des Moines 282
Shenyang 247
Hebei 230
San Diego 230
Changsha 210
Brescia 186
Rome 175
Tianjin 153
Jiaxing 147
Lancaster 135
Jinan 125
Shanghai 125
Verona 116
Florence 104
London 102
Nürnberg 102
Hangzhou 87
Kunming 86
Dearborn 60
Munich 57
Trieste 55
Kocaeli 49
San Francisco 49
Lanzhou 48
Ningbo 48
Dong Ket 47
Boardman 46
Zhengzhou 44
Los Angeles 42
Toronto 40
Bergamo 39
Turin 39
Taizhou 38
Udine 36
Guangzhou 35
Bologna 34
Haikou 34
Brussels 33
Genoa 33
Norwalk 33
Redwood City 33
Padova 31
Syracuse 30
Orange 29
Changchun 28
Pisa 26
Genova 25
Tallinn 23
Menlo Park 22
Mumbai 22
Jakarta 20
Reggio Nell'emilia 20
Strasbourg 20
Taiyuan 20
Brno 19
Kilburn 19
Augusta 18
Melbourne 18
Paris 17
Pune 17
Torino 17
San Mateo 16
Hounslow 15
Modena 15
Naples 14
Trento 14
Bari 13
Beirut 13
Desio 13
Fuzhou 13
Palermo 13
Acton 12
Chiswick 12
Ferrara 12
Hanoi 12
Hanover 12
Napoli 12
Prescot 12
Totale 36.808
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.131
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.530
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 764
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 255
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 254
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 251
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 245
Abatacept reduces levels of switched memory B cells, autoantobodies, and immunoglobulins in patients with Rheumatoid Arthritis 232
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 205
Preface. What's New in Autoimmunity: New Autoantibodies, New Therapies, New Diseases 201
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? 197
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. 189
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. 186
Long-term outcome of children of rheumatic disease patients 173
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 166
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 164
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 160
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 159
Failure of intravenous immunoglobulin to prevent congenital heartblock: Findings of a multicenter, prospective, observational study 156
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 156
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 156
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 152
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 152
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 149
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 149
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 148
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 147
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 143
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 140
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 135
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 132
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 131
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 131
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 130
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 130
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 130
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 129
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 128
Antiphospholipid antibodies mediate autoimmunity against dying cells. 127
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 125
Children born to SLE and APS mothers 125
Anti-phospholipid antibodies 123
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 123
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 122
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 122
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 122
New acquirements on an old molecule: type I interferon. 121
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 121
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 120
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 120
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 119
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 119
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 118
Management of recurrent thrombosis in antiphospholipid syndrome 118
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 117
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 117
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 117
Forum interdisciplinare per la ricerca delle malattie autoimmuni (FIRMA) study group. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. 116
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? 115
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 115
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 115
Autoimmune polyendocrine Syndromes 114
Should our approach to the anticardiolipin assay change 20 years after its discovery? 114
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 114
Beyond the "syndrome": antiphospholipid antibodies as risk factors. 114
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 114
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 114
V meeting of the European forum on antiphospholipid antibodies. 113
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 113
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 113
State of the art: Reproduction and pregnancy in rheumatic diseases. 112
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 112
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 112
Follow up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation 111
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. 111
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 111
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 111
Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. 110
Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction. 109
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 109
Endothelium and the brain in CNS lupus. 109
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'. 109
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 109
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. 109
Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. 108
Neonatal effects of maternal antiphospholipid syndrome. 108
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 108
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 108
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 107
Development of automated assays for anticardiolipin antibodies determination: addressing antigen and standardization issues. 107
Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. 107
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 107
Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome. 107
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 107
Neuropsychological development of children born to patients with systemic lupus erythematosus 106
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 106
Effetto del trattamento a breve termine con lercanidipina sulle cellule progenitrici endoteliali circolanti e sulle alterazioni strutturali delle arteriole retiniche 106
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 106
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 106
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 106
Totale 17.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 246.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 246.922
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.242 0 0 0 0 751 1.348 1.039 1.390 916 1.571 432 795
2020/20219.196 182 1.128 442 1.079 498 1.118 313 1.084 1.152 949 887 364
2021/20225.232 280 981 159 312 145 300 318 393 290 556 468 1.030
2022/20233.585 702 46 82 180 281 996 41 288 517 54 206 192
2023/20244.337 235 124 327 346 191 637 156 180 1.246 108 90 697
2024/20252.549 141 131 102 1.186 989 0 0 0 0 0 0 0
Totale 52.917